Physician profile
Christine Schuler
NPI 1962082339
$5,350.42
in general payments reported to CMS, 2019-2025
12 companies · $1,377 in 2025
The $1,377 reported for 2025 was more than what 76% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,974 · 2025: $1,377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,919 · Travel and Lodging: $1,365 · Long Term Medical Supply Or Device Loan: $66.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,919.28 |
| Travel and Lodging | $1,364.68 |
| Long Term Medical Supply Or Device Loan | $66.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,141.24 | 2024-2025 | Ortholoc 3di, Prostep, Ortholoc 2 Lapifuse |
| Smith+Nephew, INC. | $392.92 | 2024-2025 | Stravix, Grafix Pl, Collagenase Santyl |
| Integra Lifesciences Corporation | $342.35 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $320.72 | 2024-2025 | Restrata Wound Matrix |
| Organogenesis INC. | $316.89 | 2024-2025 | Apligraf, Affinity, Puraply Wound Matrix |
| Treace Medical Concepts, INC. | $151.47 | 2025 | |
| Paratek Pharmaceuticals, INC. | $140.99 | 2024-2025 | Nuzyra |
| Royal Biologics, INC. | $135.00 | 2024 | |
| Biotissue Holdings INC. | $132.09 | 2024 | |
| Abbott Laboratories | $103.85 | 2025 | Freestyle Libre 3 |
| Solventum Corporation | $101.47 | 2025 | V.A.C.Ulta, V.A.C.Instill, Prevena |
| Trice Medical, INC. | $71.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Schuler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.